2021 Clinical Trials Media Topical 
Cannabis Law Report
OCTOBER 29, 2021
(NYSE American: IGC) announces its financial results for the three months ended September 30, 2021, which is the second quarter of the Company’s 2022 fiscal year. During the six months ended September 30, 2021, the Company raised approximately $4.1 million for the three months ended September 30, 2021, from approximately $1.48
Cannabis Law Report
JUNE 30, 2021
LONDON–(BUSINESS WIRE)– Fourfive , the CBD and nutrition brand loved by athletes and those leading an active lifestyle, today called on the UK’s sports governing bodies to stop sitting if on the fence and conduct clinical trials into the effectiveness of CBD and medicinal cannabis in professional sport. fourfive.com.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 8, 2021
The Company expects to finalize the agreement with the research institute and commence studies by Fall 2021. cbdMD began its first phase of research in the Fall of 2020, with its first in vivo animal study and clinical trials. and are difficult to predict. cbdMD, Inc. and are difficult to predict. cbdMD, Inc. John Weston.
Cannabis Law Report
FEBRUARY 28, 2022
Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. 1025, 1026 (2021) (reporting significant improvement of PTSD symptoms following treatment with MDMA in clinical trial); see also Alec J. 9, 2021), [link] [ [link] ]. Yaden & Roland R.
Project CBD
FEBRUARY 28, 2023
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. in 2021 reached $2 billion, according to Statistica.) 2 The seeds of C.
Cannabis Law Report
NOVEMBER 10, 2021
In October 2021, Virpax announced that a $1.87 Also, the NIH engaged Battelle to conduct Dose Range Finding Studies, with the first study in rats being completed on October 7 th , 2021. A Dose Range Finding Study in dogs will start on November 10, 2021. A Dose Range Finding Study in dogs will start on November 10, 2021.
Cannabis Law Report
DECEMBER 28, 2021
.–(BUSINESS WIRE)– #pharma –Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX) achieved significant milestones relating to its pipeline of product candidates as of the end of 2021, which are summarized below. “I Mack, Chairman and CEO of Virpax. to conduct this study in Canada.
Expert insights. Personalized for you.
52 
Let's personalize your content